Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	34.89	44.37	61.14	28.61	12.46	6.9
Short-Term Investments	0	0	0	0	8.01	18.5
Cash & Cash Equivalents	34.89	44.37	61.14	28.61	20.48	25.4
Cash Growth	-35.52%	-27.44%	113.67%	39.75%	-19.38%	-57.37%
Receivables	0	0	0	0.06	0	0
Inventory	0	0	0	5.82	0	0
Other Current Assets	0.96	0.96	1.01	2.13	1.86	1.01
Total Current Assets	35.85	45.33	62.15	36.63	22.34	26.4
Property, Plant & Equipment	8.44	8.78	10.02	11.25	11.92	7.68
Goodwill and Intangibles	4.51	4.68	5.34	6.01	6.67	7.34
Other Long-Term Assets	0.37	0.37	0.37	0.37	0.37	0.49
Total Long-Term Assets	13.32	13.83	15.73	17.62	18.95	15.51
Total Assets	49.16	59.15	77.88	54.25	41.29	41.92
Accounts Payable	1.71	1.84	1.57	2.9	1.72	1.96
Deferred Revenue	0	0	0	0.02	0	0
Current Debt	1.1	1.06	1.81	1.21	0.54	0
Other Current Liabilities	2.27	3.81	2.6	4.39	5.33	2.5
Total Current Liabilities	5.08	6.71	5.98	8.52	7.59	4.46
Long-Term Debt	7.8	8.09	74.14	10.04	10.81	6.72
Total Long-Term Liabilities	7.8	8.09	74.14	10.04	10.81	6.72
Total Liabilities	12.88	14.79	80.13	18.56	18.4	11.18
Total Debt	8.9	9.14	75.96	11.25	11.36	6.72
Debt Growth	-88.24%	-87.96%	575.17%	-0.93%	69.01%	-
Retained Earnings	-347.05	-336.92	-294.71	-236.2	-172.54	-122.69
Comprehensive Income	0	0	0	0	-0	0
Shareholders' Equity	36.29	44.36	-2.25	35.69	22.89	30.74
Net Cash / Debt	25.99	35.22	-14.82	17.36	9.12	18.68
Net Cash / Debt Growth	-	-	-	90.42%	-51.18%	-68.65%
Net Cash Per Share	0.47	0.73	-0.44	0.62	0.39	0.90
Working Capital	30.77	38.62	56.17	28.11	14.75	21.94
Book Value Per Share	0.66	0.92	-0.07	1.28	0.98	1.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).